Should I stop varenicline (Varylar) because it is causing sleep problems during the first week?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Stop Varenicline for Sleep Issues in the First Week

Continue varenicline despite sleep disturbances during the first week, as these side effects are common, typically transient, and do not outweigh the substantial mortality benefits of smoking cessation. 1

Understanding Sleep Side Effects with Varenicline

Sleep disturbances, including insomnia, abnormal dreams, and sleep disorders are well-recognized and common side effects of varenicline. The FDA drug label explicitly lists "trouble sleeping" and abnormal dreams among the most common side effects 1. Clinical guidelines acknowledge that nicotine withdrawal symptoms typically peak within 1-2 weeks of quitting and then subside 2, making it difficult to distinguish between medication side effects and withdrawal symptoms during this initial period.

Evidence on Sleep Problems with Varenicline

Research demonstrates that:

  • Varenicline is associated with increased risk of sleep disorders (OR 1.63), insomnia (OR 1.56), and abnormal dreams (OR 2.38) compared to placebo 3
  • These sleep-related adverse events are dose-dependent 4
  • Despite these effects, there is no increased risk of serious neuropsychiatric events, depression, suicidal ideation, or death with varenicline 3, 5

Management Strategy

Continue Treatment with Monitoring

Follow-up is recommended within 2-3 weeks after starting pharmacotherapy to assess side effects 2. This timing is specifically designed to address early side effects like sleep disturbances.

Dose Adjustment Options if Sleep Problems Persist

If sleep issues remain intolerable after the first 2-3 weeks:

  • For vivid dreams/nightmares: Consider switching to 1 mg once daily in the morning only (instead of 1 mg twice daily) 6
  • For general insomnia: Consider dose reduction to 0.5 mg twice daily 4, 6
  • Lower doses eliminate many adverse effects while retaining most efficacy for smoking cessation 4
  • One study showed patients taking an average of 1.3 mg/day achieved abstinence rates >40% at 12 weeks 4

When to Actually Stop Varenicline

Discontinue varenicline only if:

  • Serious neuropsychiatric symptoms develop (depression, suicidal ideation, agitation) 2
  • Patient has brain metastases (seizure risk) 2
  • Sleep disturbances remain intolerable despite dose adjustment after 2-3 weeks

Alternative if Varenicline Must Be Stopped

If varenicline cannot be tolerated even at lower doses, switch to combination NRT (nicotine patch + short-acting NRT like gum/lozenge) 2. This is equally effective as varenicline and has fewer sleep-related side effects 7.

Critical Context

The substantial mortality benefits of immediate smoking cessation far outweigh the risks of temporary sleep disturbances 2, 7. Stopping varenicline prematurely in the first week—when withdrawal symptoms are also peaking—significantly reduces the chance of successful smoking cessation, which directly impacts long-term morbidity and mortality.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.